Thermo Fisher's Q3 earnings boosted by COVID-19 sales
October 21, 2020 -- Products related to the novel coronavirus are spelling success for Thermo Fisher, which reported that revenue was up by 36% in the third quarter to $8.52 billion, compared with $6.27 billion the same period last year.
Bruker launches Vutara super-resolution microscope
October 21, 2020 -- Bruker has announced the launch of the Vutara VXL super-resolution fluorescence microscope for use in nanoscale biomedical imaging.
Reaction Biology, 4HF Biotec offer new cell-based services
October 19, 2020 -- Reaction Biology and 4HF Biotec announced that they are offering a new cell-based service that will give customers a comprehensive understanding of their candidates. The service will combine Reaction's ProLiFiler cell assay service with 4HF's Biomarker Analysis and Mode of Action (MoA) Finder tools
Precigen nabs FDA nod for manufacturing UltraCAR-T therapies
October 15, 2020 -- Precigen has been granted clearance by the U.S. Food and Drug Administration (FDA) for its UltraPorator system. The system also had a successful technology transfer to clinical sites and will be used as a manufacturing device for Precigen's investigational UltraCAR-T therapies.
Castle Creek begins gene therapy clinical trial for scleroderma
October 15, 2020 -- Castle Creek Biosciences has initiated a phase I/II clinical trial evaluating FCX-013, the company's investigational gene therapy for the treatment of moderate to severe localized scleroderma.
Sestina Bio to develop digital cell engineering platform
October 15, 2020 -- Sestina Bio, a new company developing an automated synthetic biology platform, has been launched with seed funding. Sestina also is the first company to be launched from the Foresite Labs incubator.
Qiagen sales, earnings climb in Q3
October 14, 2020 -- Significant ongoing demand for COVID-19 testing and improved trends in other areas of Qiagen's product portfolio led to a 26% increase in preliminary net sales for the company during its third quarter.
Atum licenses cell line development tools to Rentschler Biopharma
October 14, 2020 -- Rentschler Biopharma has signed a full contract development and manufacturing organization license agreement for Atum's leap-in transposase platform.
ERS Genomics licenses gene editing tech to FASMAC
October 14, 2020 -- ERS Genomics, which has access to foundational CRISPR/Cas9 intellectual property co-owned by Emmanuelle Charpentier, has signed an agreement with FASMAC of Japan.
Dyno Therapeutics licenses AAV platform to Roche
October 14, 2020 -- Dyno Therapeutics has licensed its CapsidMap platform for the development of next-generation adeno-associated virus (AAV) vectors for gene therapies for central nervous system diseases and liver-directed therapies to Roche and its subsidiary Spark Therapeutics.
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter